Aviva’s AMERISAFE AMSF Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-11,606
Closed -$581K 959
2023
Q3
$581K Sell
11,606
-14,924
-56% -$783K ﹤0.01% 815
2023
Q2
$1.41M Sell
26,530
-1,700
-6% -$90.5K 0.01% 750
2023
Q1
$1.38M Buy
28,230
+9,344
+49% +$490K 0.01% 810
2022
Q4
$982K Sell
18,886
-14,219
-43% -$753K ﹤0.01% 843
2022
Q3
$1.55M Sell
33,105
-7,328
-18% -$354K 0.01% 765
2022
Q2
$2.1M Buy
40,433
+10,135
+33% +$493K 0.01% 778
2022
Q1
$1.5M Sell
30,298
-16,015
-35% -$818K 0.01% 913
2021
Q4
$2.49M Buy
46,313
+16,133
+53% +$902K 0.01% 808
2021
Q3
$1.7M Buy
+30,180
New +$1.72M 0.01% 800

Other funds holding AMSF

Aviva's AMSF Position: Q4 2023 in Review

Aviva sold out of AMERISAFE (AMSF) in Q4 2023, closing a stake of 11,606 shares — an estimated $581K sold.

Aviva first reported a position in AMSF in Q3 2021 and held it in 9 quarters. The position peaked at $2.49M in Q4 2021. 162 funds tracked by Wall St. Rank hold AMSF as of Q4 2023.

  • Aviva reported no remaining AMERISAFE position as of Q4 2023 after selling out during the quarter.
  • Aviva sold 11,606 AMERISAFE shares in Q4 2023, an estimated $581K.
  • Aviva first reported a position in AMERISAFE in Q3 2021 and held it in 9 quarters.
  • Aviva's AMERISAFE position peaked at $2.49M in Q4 2021.
  • 162 funds tracked by Wall St. Rank held AMERISAFE as of Q4 2023.

Based on Aviva's 13F filing for Q4 2023, filed 9 Feb 2024.